MedTrace Logo

Cardiac Rehab Retrospective Review (CR3)

NCT04675957 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 55

Last updated 2022-04-14

No results posted yet for this study

Summary

All patients enrolled in the Austrian LifeVest Registry will be retrospectively screened for successfully completed ambulatory or stationary rehabilitation program. Baseline characteristics, complete rehab data, outcomes and follow up data, as well as wearable cardioverter defibrillator(WCD)-derived data will be collected from these patients.

Specifically, performance data from the start of the exercise training (ET) will be compared to the end of ET; including type of training, exertion, time and duration will be collected. In addition, WCD recorded data such as automatically and manually recorded ECGs, compliance, and TRENDS data will be collected.

Conditions

Interventions

OTHER

cardiac rehabilitation

stationary or ambulatory cardiac rehabilitation

Sponsors & Collaborators

  • Zoll Medical Corporation

    collaborator INDUSTRY

  • Medical University of Graz

    lead OTHER

Principal Investigators

  • Daniel Scherr, MD · Medical University of Graz

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-01
Primary Completion
2022-04-12
Completion
2022-04-12

Countries

  • Austria

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04675957 on ClinicalTrials.gov